carbon monoxide and sr141716

carbon monoxide has been researched along with sr141716 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonelli, T; Carratù, MR; Cassano, T; Cuomo, V; Ferraro, L; Finetti, S; Mazzoni, E; Tanganelli, S; Tattoli, M; Tomasini, MC; Trabace, L1
Noble, EP; Oskooilar, N; Wilcox, CS1

Trials

1 trial(s) available for carbon monoxide and sr141716

ArticleYear
ANKK1/DRD2 locus variants are associated with rimonabant efficacy in aiding smoking cessation: pilot data.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2011, Volume: 59, Issue:8

    Topics: Carbon Monoxide; Genetic Loci; Humans; Pilot Projects; Piperidines; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Pyrazoles; Receptors, Dopamine D2; Rimonabant; Smoking Cessation; Treatment Outcome

2011

Other Studies

1 other study(ies) available for carbon monoxide and sr141716

ArticleYear
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
    Neurochemistry international, 2006, Volume: 49, Issue:6

    Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Carbon Monoxide; Carboxyhemoglobin; Cells, Cultured; Cerebral Cortex; Extracellular Space; Female; Glutamates; Morpholines; Naphthalenes; Piperidines; Potassium; Pregnancy; Pyrazoles; Rats; Rats, Wistar; Reproduction; Rimonabant

2006
chemdatabank.com